Your browser doesn't support javascript.
loading
Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals.
Szekanecz, Zoltán; Vokó, Zoltán; Surján, Orsolya; Rákóczi, Éva; Szamosi, Szilvia; Szucs, Gabriella; Szekanecz, Éva; Müller, Cecília; Kiss, Zoltán.
Afiliación
  • Szekanecz Z; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Vokó Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
  • Surján O; Syreon Research Institute, Budapest, Hungary.
  • Rákóczi É; Department of Deputy Chief Medical Officer II., National Public Health Center Management, Budapest, Hungary.
  • Szamosi S; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Szucs G; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Szekanecz É; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Müller C; Department of Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Kiss Z; Department of Chief Medical Officer, National Public Health Center Management, Budapest, Hungary.
Front Immunol ; 14: 1247129, 2023.
Article en En | MEDLINE | ID: mdl-38022626
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Hungria